186 related articles for article (PubMed ID: 2683206)
1. Hyperimmunized patients do not need to wait for an HLA identical donor.
Claas FH; van Leeuwen A; van Rood JJ
Tissue Antigens; 1989 Jul; 34(1):23-9. PubMed ID: 2683206
[TBL] [Abstract][Full Text] [Related]
2. The hyperimmunized patient: from sensitization toward transplantation.
Claas FH; van Rood JJ
Transpl Int; 1988 Jul; 1(2):53-7. PubMed ID: 3076380
[TBL] [Abstract][Full Text] [Related]
3. Negative cross-match selection of HLA-DR compatible kidneys for highly sensitised patients.
Claas FH
Immunol Lett; 1991 Jul; 29(1-2):61-4. PubMed ID: 1916926
[TBL] [Abstract][Full Text] [Related]
4. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
5. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
[No Abstract] [Full Text] [Related]
6. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
7. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
[TBL] [Abstract][Full Text] [Related]
8. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
[No Abstract] [Full Text] [Related]
9. Class I peptides involved in the indirect pathway of allorecognition.
Takemoto SK; Cecka JM; Gjertson DW; Terasaki PI
Transplant Proc; 1999; 31(1-2):781. PubMed ID: 10083332
[No Abstract] [Full Text] [Related]
10. Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.
Kosmoliaptsis V; Gjorgjimajkoska O; Sharples LD; Chaudhry AN; Chatzizacharias N; Peacock S; Torpey N; Bolton EM; Taylor CJ; Bradley JA
Kidney Int; 2014 Nov; 86(5):1039-48. PubMed ID: 24717292
[TBL] [Abstract][Full Text] [Related]
11. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
Middleton D; Martin J; Magee BA; Douglas JF
Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
[No Abstract] [Full Text] [Related]
12. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
[No Abstract] [Full Text] [Related]
13. Kidney graft failure and presensitization against HLA class I and class II antigens.
Süsal C; Opelz G
Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
[TBL] [Abstract][Full Text] [Related]
14. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
15. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
16. Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients.
Reisaeter AV; Leivestad T; Fauchald P; Brekke I; Thorsby E
Transplant Proc; 1997 Nov; 29(7):3099-100. PubMed ID: 9365682
[No Abstract] [Full Text] [Related]
17. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
[TBL] [Abstract][Full Text] [Related]
18. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
20. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
